Navigation Links
BioHealth Innovation, Inc. President & CEO Richard Bendis to Present at SXSW 2013 & 2013 BIO International Convention
Date:3/4/2013

ROCKVILLE, Md., March 4, 2013 /PRNewswire/ -- BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, today announced that BioHealth Innovation, Inc. President & CEO Richard Bendis is scheduled to present at the upcoming SXSW 2013 conference and the 2013 BIO International Convention this Spring. Mr. Bendis is also serving on the Program Committee for AdvaMed 2013: The MedTech Conference, which will be held in Washington, DC, in September.

Specific information for each event is as follows:

  • 2013 South By Southwest "SXSW" Conference, March 8-12, 2013, Austin Convention Center, Austin, Texas. Mr. Bendis is participating in a panel on Saturday, March 9, entitled, "Entrepreneurs-in-Residence: Not Just for VCs!" Venture capital firms have utilized the services of 'Entrepreneurs-in-Residence' (EIRs), seasoned innovators with functional expertise, to help spur entrepreneurship and fill gaps in expertise. This panel will look at the value of combining the 'innovation mojo' of EIRs with some of the government's brightest 'intrapreneurs' to solve the nation's most pressing challenges. Joining Mr. Bendis on the panel will be Arnaub Chatterjee (Associate Director of Health Information Partnerships, Merck - Office of the Chief Medical Information and Innovation Officer), John Paul Farmer (Senior Advisor to the U.S. CTO) and Zachery Jiwa , Health IT Advisor; Innovation Fellow, U.S. Department of Health and Human Services; Advisor, HIMSS State Advisory Roundtable.
  • 2013 BIO International Convention, April 22-23, 2013, McCormick Place, Chicago, Illinois. Mr. Bendis is scheduled to be part of The Translational Research Forum on April 22, 2013, beginning at 1:30 p.m., and a panel discussion focused on effective strategies in developing accelerator models beginning at 4:35 p.m.
  • AdvaMed 2013: The MedTech Conference, September 23-25, 2013, Walter E. Washington Convention Center, Washington, DC. Mr. Bendis is reviewing panel submissions in the eHealth IT Track.

About BioHealth Innovation, Inc.
BioHealth Innovation, Inc., is a regional innovation intermediary focused on commercializing market-relevant bio-health innovations and increasing access to early-stage funding in Maryland. Learn more at www.biohealthinnovation.org.


'/>"/>
SOURCE BioHealth Innovation, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. BioHealth Innovation, Inc. Appoints Qiagens Douglas Liu to Board of Directors
2. Economic Alliance of Greater Baltimore Inks Business Partnership with BioHealth Innovation to Bring Health and Life Sciences Research to Market
3. BioHealth Innovation, Inc. Caps Next Phase Of Development With Move To New Headquarters And Addition Of Staff
4. Two Baltimore Business Leaders are BioHealth Innovation, Inc.s Newest Board Members
5. BioHealth Innovation, Inc. Forms Commercial Relevance Advisory Board to Help Advance Market-Relevant Innovations in Central Maryland
6. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
7. Elsevier / MEDai Appoints Tom Zajac as New President
8. GenVec President and Chief Executive Officer Announces Retirement
9. Michael A. Marletta Takes Office as New President of Scripps Research Institute
10. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
11. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Iowa (PRWEB) , ... October 12, 2017 , ... ... based in Vilnius, Lithuania, announced today that they have entered into a multiyear ... is to provide CRISPR researchers with additional tools for gene editing across all ...
(Date:10/12/2017)... ... 2017 , ... AMRI, a global contract research, development and ... outcomes and quality of life, will now be offering its impurity solutions as ... regulatory requirements for all new drug products, including the finalization of ICH M7 ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 system ... experiments and avoiding the use of exogenous expression plasmids. The simplicity of programming ... systematic gain-of-function studies. , This complement to loss-of-function studies, such as with ...
(Date:10/11/2017)... ... 11, 2017 , ... Proscia Inc ., a data ... titled, “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, ... and how Proscia improves lab economics and realizes an increase in diagnostic confidence.* ...
Breaking Biology Technology:
(Date:4/5/2017)... SEATTLE , April 5, 2017  The Allen ... the Allen Cell Explorer: a one-of-a-kind portal and dynamic ... large-scale 3D imaging data, the first application of deep ... edited human stem cell lines and a growing suite ... the platform for these and future publicly available resources ...
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):